Immunogenicity and safety of Intanza^®/IDflu^® intradermal influenza vaccine in South Korean adults: A multicenter, randomized trial

References

• Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179 - 86; http://dx.doi.org/10.1001/jama.289.2.179; PMID: 12517228
   PubMed Web of Science ®Google Scholar
• World Health Organization. Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec 2012; 87:461 - 76; PMID: 23210147
   PubMedGoogle Scholar
• World Health Organization. World Health Organization 56th World Health Assembly. Prevention and control of influenza pandemics and annual epidemics. Geneva, 2003. WHA56.19.
   Google Scholar
• Monto AS. Preventing influenza in healthy adults: the evolving story. JAMA 2000; 284:1699 - 701; http://dx.doi.org/10.1001/jama.284.13.1699; PMID: 11015802
   PubMed Web of Science ®Google Scholar
• Monto AS. Seasonal influenza and vaccination coverage. Vaccine 2010; 28:Suppl 4 D33 - 44; http://dx.doi.org/10.1016/j.vaccine.2010.08.027; PMID: 20713259
   PubMedGoogle Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159 - 69; http://dx.doi.org/10.1016/j.vaccine.2005.08.105; PMID: 16213065
   PubMed Web of Science ®Google Scholar
• Arnou R, Eavis P, Pardo JR, Ambrozaitis A, Kazek MP, Weber F. Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial. Hum Vaccin 2010; 6:346 - 54; http://dx.doi.org/10.4161/hv.6.4.10961; PMID: 20372053
   PubMed Web of Science ®Google Scholar
• Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 2009; 27:7304 - 12; http://dx.doi.org/10.1016/j.vaccine.2009.10.033; PMID: 19849996
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008; 198:650 - 8; http://dx.doi.org/10.1086/590434; PMID: 18652550
   PubMed Web of Science ®Google Scholar
• Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004; 4:211 - 22; http://dx.doi.org/10.1038/nri1310; PMID: 15039758
   PubMed Web of Science ®Google Scholar
• Valladeau J, Saeland S. Cutaneous dendritic cells. Semin Immunol 2005; 17:273 - 83; http://dx.doi.org/10.1016/j.smim.2005.05.009; PMID: 15953735
   PubMed Web of Science ®Google Scholar
• Schröder JM, Reich K, Kabashima K, Liu FT, Romani N, Metz M, et al. Who is really in control of skin immunity under physiological circumstances - lymphocytes, dendritic cells or keratinocytes?. Exp Dermatol 2006; 15:913 - 29; PMID: 17002689
   PubMed Web of Science ®Google Scholar
• Coleman PJ, Shaw FE Jr., Serovich J, Hadler SC, Margolis HS. Intradermal hepatitis B vaccination in a large hospital employee population. Vaccine 1991; 9:723 - 7; http://dx.doi.org/10.1016/0264-410X(91)90287-G; PMID: 1836918
   PubMed Web of Science ®Google Scholar
• Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004; 351:2295 - 301; http://dx.doi.org/10.1056/NEJMoa043540; PMID: 15525714
   PubMed Web of Science ®Google Scholar
• Lang J, Hoa DQ, Gioi NV, Vien NC, Nguyen CV, Rouyrre N, et al. Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial. Trans R Soc Trop Med Hyg 1999; 93:208 - 13; http://dx.doi.org/10.1016/S0035-9203(99)90309-7; PMID: 10450451
   PubMed Web of Science ®Google Scholar
• Micozkadioglu H, Zumrutdal A, Torun D, Sezer S, Ozdemir FN, Haberal M. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. Ren Fail 2007; 29:285 - 8; http://dx.doi.org/10.1080/08860220601166263; PMID: 17497441
   PubMed Web of Science ®Google Scholar
• Beran J, Ambrozaitis A, Laiskonis A, Mickuviene N, Bacart P, Calozet Y, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009; 7:13; http://dx.doi.org/10.1186/1741-7015-7-13; PMID: 19341446
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007; 25:8833 - 42; http://dx.doi.org/10.1016/j.vaccine.2007.10.020; PMID: 18023942
   PubMed Web of Science ®Google Scholar
• Atmar RL, Patel SM, Keitel WA. Intanza(®): a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines 2010; 9:1399 - 409; http://dx.doi.org/10.1586/erv.10.134; PMID: 21105776
   PubMed Web of Science ®Google Scholar
• Van Damme P, Arnou R, Kafeja F, Fiquet A, Richard P, Thomas S, et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. BMC Infect Dis 2010; 10:134; http://dx.doi.org/10.1186/1471-2334-10-134; PMID: 20504306
   PubMed Web of Science ®Google Scholar
• Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009; 200:172 - 80; http://dx.doi.org/10.1086/599790; PMID: 19508159
   PubMed Web of Science ®Google Scholar
• Zakay-Rones Z. Human influenza vaccines and assessment of immunogenicity. Expert Rev Vaccines 2010; 9:1423 - 39; http://dx.doi.org/10.1586/erv.10.144; PMID: 21105778
   PubMed Web of Science ®Google Scholar
• Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 2007; 25:659 - 63; http://dx.doi.org/10.1016/j.vaccine.2006.08.026; PMID: 17011678
   PubMed Web of Science ®Google Scholar
• Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004; 351:2286 - 94; http://dx.doi.org/10.1056/NEJMoa043555; PMID: 15525713
   PubMed Web of Science ®Google Scholar
• Arnou R, Frank M, Hagel T, Prébet A. Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Adv Ther 2011; 28:555 - 65; http://dx.doi.org/10.1007/s12325-011-0035-z; PMID: 21626269
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Vets E, Freese R, Seiberling M, Weber F, Salamand C, et al. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Vaccine 2008; 26:6614 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.09.078; PMID: 18930093
   PubMed Web of Science ®Google Scholar
• Reygrobellet C, Viala-Danten M, Meunier J, Weber F, Nguyen VH. Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials. Hum Vaccin 2010; 6:336 - 45; http://dx.doi.org/10.4161/hv.6.4.10753; PMID: 20372083
   PubMed Web of Science ®Google Scholar
• Duggan ST, Plosker GL. Intanza 15 microg intradermal seasonal influenza vaccine: in older adults (aged >or=60 years). Drugs Aging 2010; 27:597 - 605; http://dx.doi.org/10.2165/11203880-000000000-00000; PMID: 20583853
   PubMed Web of Science ®Google Scholar
• European Medicines Agency (EMA) Committee for Medicinal Products for Human Use. Note for guidance on harmonisation of requirements for influenza vaccines. 1997. CPMP/BWP/214/96.
   Google Scholar
• Center for Biologics Evaluation and Research. U.S. Food and Drug Administration. Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials. 2007.
   Google Scholar
• Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17:857 - 72; http://dx.doi.org/10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; PMID: 9595616
   PubMed Web of Science ®Google Scholar